InvestorsHub Logo
Followers 58
Posts 10057
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Tuesday, 06/21/2022 12:45:16 PM

Tuesday, June 21, 2022 12:45:16 PM

Post# of 458956
https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/88412664/anavex-life-sciences-announces-its-very-first-scie

Today's video release presents a well planned and executed Bio Pharma set of CNS disease treatment programs with a leadership spirit not shown before, by AVXL or competitors. There were no misses/big surprises.

AVXL obviously has a structured-organized-funded program management plan . It is comforting to know they are not loosely doing this critical development work as an asynchronous collection of random events and activities as can often happen under such circumstances. Each trial can clearly spin off new AI-BIO knowledge. Looking forward to future multiple TRIFECTA'S.

Suddenly the future for CNS disease patients (including RARE cases) is making more sense as our knowledge pool expands. WELL DONE.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News